AstraZeneca delivers positive late-stage trial results from unique cancer drug combination
Positive data from cancer drug combinationHuge unmet need to treat endometrial cancerFurther data requiredPharmaceutical giant AstraZeneca (AZN) said positive results from a late-stage trial showed a combination of its cancer drugs...
26 May 2023